Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)
暂无分享,去创建一个
E. Diamandis | M. Hollenberg | M. Blaber | I. Tea | K. Oikonomopoulou | Kristina K. Hansen | M. Saifeddine | N. Vergnolle | S. Blaber | I. Scarisbrick | Katerina Oikonomopoulou
[1] N. Vergnolle,et al. CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT , 2005, Gut.
[2] Thomas A Luger,et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. , 2005, Endocrine reviews.
[3] E. Diamandis,et al. The emerging roles of human tissue kallikreins in cancer , 2004, Nature Reviews Cancer.
[4] M. Hollenberg,et al. Proteinase‐activated receptor‐4: evaluation of tethered ligand‐derived peptides as probes for receptor function and as inflammatory agonists in vivo , 2004, British journal of pharmacology.
[5] E. Diamandis,et al. Human tissue kallikreins: physiologic roles and applications in cancer. , 2004, Molecular cancer research : MCR.
[6] N. Bunnett,et al. Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.
[7] N. Vergnolle. Modulation of visceral pain and inflammation by protease‐activated receptors , 2004, British journal of pharmacology.
[8] D. Katsaros,et al. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. , 2003, Cancer research.
[9] M. Hollenberg,et al. Proteinase-activated receptors in the nervous system , 2003, Nature Reviews Neuroscience.
[10] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[11] Peter F M Choong,et al. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis. , 2003, Clinical orthopaedics and related research.
[12] J. Wallace,et al. Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism. , 2003, Canadian journal of physiology and pharmacology.
[13] G. Yousef,et al. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. , 2003, Cancer research.
[14] W. Ruf,et al. Specificity of coagulation factor signaling , 2003, Journal of thrombosis and haemostasis : JTH.
[15] M. Hollenberg,et al. Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling. , 2002, The Biochemical journal.
[16] J. Wallace,et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. , 2002, The American journal of pathology.
[17] M. Hollenberg,et al. Restricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aorta. , 2002, Canadian journal of physiology and pharmacology.
[18] C. Lucchinetti,et al. Activity of a newly identified serine protease in CNS demyelination. , 2002, Brain : a journal of neurology.
[19] M. Hollenberg,et al. International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.
[20] M. Hollenberg,et al. Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin. , 2002, The Journal of pharmacology and experimental therapeutics.
[21] Moses Rodriguez,et al. Enzymatic properties of rat myelencephalon-specific protease. , 2002, Biochemistry.
[22] K. Fujikawa,et al. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. , 2001, Biochemistry.
[23] A. Basbaum,et al. Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway , 2001, Nature Medicine.
[24] M. Hollenberg,et al. Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides. , 2001, Canadian journal of physiology and pharmacology.
[25] D. Katsaros,et al. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer , 2001, British Journal of Cancer.
[26] J. Wallace,et al. Protease-activated receptors in inflammation, neuronal signaling and pain. , 2001, Trends in pharmacological sciences.
[27] G. Yousef,et al. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. , 2000, Clinical biochemistry.
[28] S. Coughlin,et al. Thrombin signalling and protease-activated receptors , 2000, Nature.
[29] J. Wallace,et al. Characterization of the inflammatory response to proteinase‐activated receptor‐2 (PAR2)‐activating peptides in the rat paw , 1999, British journal of pharmacology.
[30] M. Hollenberg,et al. Thrombin and mast cell tryptase regulate guinea‐pig myenteric neurons through proteinase‐activated receptors‐1 and −2 , 1999, The Journal of physiology.
[31] J. Wallace,et al. Pro‐ and anti‐inflammatory actions of thrombin: a distinct role for proteinase‐activated receptor‐1 (PAR1) , 1999, British journal of pharmacology.
[32] K. Shigemasa,et al. Increased Expression of Protease M in Ovarian Tumors , 1999, Tumor Biology.
[33] J. Jesty,et al. Mitogenic Responses Mediated Through the Proteinase-Activated Receptor-2 Are Induced by Expressed Forms of Mast Cell α- or β-Tryptases , 1997 .
[34] M. Hollenberg,et al. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Hollenberg,et al. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. , 1997, Canadian journal of physiology and pharmacology.
[36] C. Lazure,et al. Prostatic kallikrein hK2, but not prostate‐specific antigen (hK3), activates single‐chain urokinase‐type plasminogen activator , 1997, International journal of cancer.
[37] J. Hoxie,et al. Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.
[38] M. Hollenberg,et al. Rat proteinase‐activated receptor‐2 (PAR‐2): cDNA sequence and activity of receptor‐derived peptides in gastric and vascular tissue , 1996, British journal of pharmacology.
[39] M. Hollenberg,et al. Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides. , 1996, Molecular pharmacology.
[40] M. Hollenberg,et al. Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. , 1995, Canadian journal of physiology and pharmacology.
[41] C. Wahlestedt,et al. Molecular cloning of a potential proteinase activated receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Hollenberg,et al. Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes. , 1993, Molecular pharmacology.
[43] J. Pouysségur,et al. cDNA cloning and expression of a hamster α‐thrombin receptor coupled to Ca2+ mobilization , 1991 .
[44] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[45] M. Hollenberg,et al. Proteinase-Activated Receptor-2 Induction by Neuroinflammation Prevents Neuronal Death during HIV Infection , 2005 .
[46] G. D. Hunter,et al. Proteinase-activated receptors. , 2001, Pharmacological reviews.
[47] M. Hollenberg,et al. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. , 1999, The Journal of pharmacology and experimental therapeutics.
[48] J. Jesty,et al. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha- or beta-tryptases. , 1997, Blood.
[49] J. Pouysségur,et al. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. , 1991, FEBS letters.